TrialJournal of hepatology2012

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

Jordi Bruix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.